BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 18172224)

  • 1. Increased incidence of in-stent thrombosis related to cocaine use: case series and review of literature.
    Singh S; Arora R; Khraisat A; Handa K; Bahekar A; Trivedi A; Khosla S
    J Cardiovasc Pharmacol Ther; 2007 Dec; 12(4):298-303. PubMed ID: 18172224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dual low response to acetylsalicylic acid and clopidogrel is associated with myonecrosis and stent thrombosis after coronary stent implantation.
    Eshtehardi P; Windecker S; Cook S; Billinger M; Togni M; Garachemani A; Meier B; Hess OM; Wenaweser P
    Am Heart J; 2010 May; 159(5):891-898.e1. PubMed ID: 20435201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased long term rates of stent thrombosis and mortality in patients given clopidogrel as compared to ticlopidine following coronary stent implantation.
    Wolak A; Amit G; Cafri C; Gilutz H; Ilia R; Zahger D
    Int J Cardiol; 2005 Sep; 103(3):293-7. PubMed ID: 16098392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High incidence of recurrent in stent thrombosis after successful treatment of a first in stent thrombosis.
    Lemesle G; Sudre A; Modine T; Delhaye C; Rosey G; Gourlay T; Bauters C; Lablanche JM
    Catheter Cardiovasc Interv; 2008 Oct; 72(4):470-8. PubMed ID: 18814219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Optimal platelet inhibition after coronary stent implantation. Current status].
    Silber S; Hoffmeister HM; Bode C
    Herz; 2008 Jun; 33(4):244-53. PubMed ID: 18581073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute stent thrombosis in the setting of cocaine abuse following percutaneous coronary intervention.
    Makaryus JN; Volfson A; Azer V; Bogachuk E; Lee A
    J Interv Cardiol; 2009 Feb; 22(1):77-82. PubMed ID: 18775054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of two-year clopidogrel + aspirin in abolishing the risk of very late thrombosis after drug-eluting stent implantation (from the TYCOON [two-year ClOpidOgrel need] study).
    Tanzilli G; Greco C; Pelliccia F; Pasceri V; BarillĂ  F; Paravati V; Pannitteri G; Gaudio C; Mangieri E
    Am J Cardiol; 2009 Nov; 104(10):1357-61. PubMed ID: 19892050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coronary artery stents: II. Perioperative considerations and management.
    Newsome LT; Weller RS; Gerancher JC; Kutcher MA; Royster RL
    Anesth Analg; 2008 Aug; 107(2):570-90. PubMed ID: 18633036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of prasugrel versus clopidogrel on outcomes among patients with acute coronary syndrome undergoing percutaneous coronary intervention without stent implantation: a TRial to assess Improvement in Therapeutic Outcomes by optimizing platelet inhibitioN with prasugrel (TRITON)-Thrombolysis in Myocardial Infarction (TIMI) 38 substudy.
    Pride YB; Wiviott SD; Buros JL; Zorkun C; Tariq MU; Antman EM; Braunwald E; Gibson CM;
    Am Heart J; 2009 Sep; 158(3):e21-6. PubMed ID: 19699846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of clopidogrel resistance on thrombotic events after percutaneous coronary intervention with drug-eluting stent.
    Wang ZJ; Zhou YJ; Liu YY; Yu M; Shi DM; Zhao YX; Guo YH; Cheng WJ; Jia de A; Cao Z; Nie B; Ge HL; Yang SW; Yan ZX
    Thromb Res; 2009 May; 124(1):46-51. PubMed ID: 19041120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictive values of post-treatment adenosine diphosphate-induced aggregation and vasodilator-stimulated phosphoprotein index for stent thrombosis after acute coronary syndrome in clopidogrel-treated patients.
    Cuisset T; Frere C; Quilici J; Gaborit B; Castelli C; Poyet R; Bali L; Morange PE; Alessi MC; Bonnet JL
    Am J Cardiol; 2009 Oct; 104(8):1078-82. PubMed ID: 19801028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased incidence of stent thrombosis in patients with cocaine use.
    Karlsson G; Rehman J; Kalaria V; Breall JA
    Catheter Cardiovasc Interv; 2007 Jun; 69(7):955-8. PubMed ID: 17492789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hidden drugs, hidden risks--is cocaine use a new risk factor for stent thrombosis?
    Lemos PA
    Catheter Cardiovasc Interv; 2007 Jun; 69(7):959-60. PubMed ID: 17525956
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparison of two antiplatelet regimens (aspirin alone versus aspirin + ticlopidine or clopidogrel) after intracoronary implantation of a carbofilm-coated stent.
    Bartorelli AL; Tamburino C; Trabattoni D; Galassi A; Serdoz R; Sheiban I; Piovaccari G; Zimarino M; Benassi A; Di Mario C; Sangiorgio P; Chierchia S; Reimers B;
    Am J Cardiol; 2007 Apr; 99(8):1062-6. PubMed ID: 17437728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term outcomes in treating left main trifurcation coronary artery disease with the Paclitaxel-eluting stent.
    Shammas NW; Dippel EJ; Avila A; Gehbauer L; Farland L; Brosius S; Jerin M; Winter M; Stoakes P; Byrd J; Majetic L; Shammas G; Sharis P; Robken J
    J Invasive Cardiol; 2007 Feb; 19(2):77-82. PubMed ID: 17268042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Temporal relation between Clopidogrel cessation and stent thrombosis after drug-eluting stent implantation.
    Roy P; Bonello L; Torguson R; Okabe T; Pinto Slottow TL; Steinberg DH; Kaneshige K; Xue Z; Satler LF; Kent KM; Suddath WO; Pichard AD; Lindsay J; Waksman R
    Am J Cardiol; 2009 Mar; 103(6):801-5. PubMed ID: 19268735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Percutaneous coronary intervention: assessing coronary vascular risk associated with bare-metal and drug-eluting stents.
    Spinler SA
    Am J Manag Care; 2009 Mar; 15(2 Suppl):S42-7. PubMed ID: 19355808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ticlopidine and aspirin therapy following implantation of coronary artery stents.
    Hobson AG; Sowinski KM
    Ann Pharmacother; 1997 Jun; 31(6):770-2. PubMed ID: 9184720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Very late stent thrombosis after dual antiplatelet therapy discontinuation in a patient with a history of acute stent thrombosis.
    Bhatt SH; Hauser TH
    Ann Pharmacother; 2008 May; 42(5):708-12. PubMed ID: 18381843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug-specific thienopyridine resistance in patient with recurrent coronary stent thrombosis.
    Milicic D; Skoric B; Lovric D
    J Invasive Cardiol; 2009 Aug; 21(8):E157-60. PubMed ID: 19652267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.